Navigation Links
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Date:5/18/2009

In August 2006, Schering-Plough and Novartis announced an agreement for the joint worldwide development and commercialization of a fixed-dose combination treatment containing Schering-Plough's mometasone furoate and Novartis' indacaterol. Indacaterol is currently under regulatory review in the U.S. and European Union.

About asthma and COPD

Asthma is a chronic inflammatory lung disease that affects 300 million people worldwide, with an estimated 15 million suffering from a severe form of the disease.(2) Their health and quality of daily life are often severely affected, and more than 180,000 people die from asthma each year throughout the world.(3)

COPD, the world's fourth most common cause of death, is an irreversible and chronic obstruction of the airways, which is caused primarily by smoking. It is estimated that the disease is prevalent in 4 percent of the population in the USA, Europe and Japan, and that at least one in 15 smokers suffers from COPD. COPD progresses slowly and eventually leads to a largely irreversible loss of lung function.

About ASMANEX

ASMANEX is approved for the maintenance treatment of asthma in patients 4 years of age and older. ASMANEX will not relieve sudden asthma symptoms and is not for children less than 4 years of age.

In the U.S., it is available in two dose strengths, 110 mcg for children between 4 and 11 years old, and 220 mcg for patients 12 and older.

Important Safety Information

ASMANEX is not a rescue inhaler and should not be used to treat sudden asthma symptoms. Use a rescue inhaler to relieve sudden asthma symptoms.

ASMANEX should not be used to treat acute asthma episodes (including status asthmaticus) where extra measures are required.

ASMANEX is not for patients who have a hypersensitivity (including allergic reactions) to mometasone or any of the in
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Schering-Plough Schedules Webcast For Annual Meeting of Shareholders
2. Schering-Plough Schedules Conference Call Webcast for 2009 First Quarter Earnings
3. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
4. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
5. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
6. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
7. Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
8. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
9. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
10. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
11. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 The largest international professional organization ... and therapeutic derivatives thereof has endorsed an educational ... about the challenges of adulterated herb and botanical ... The Society for Medicinal Plant and ...
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the leader ... the new Director of Product Strategy. In this role, Michelle ... iLab sub-teams to guide in the development of iLab products. ... the maximum possible benefit to the scientific community by offering ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation ... developing and commercializing innovative therapies addressing major unmet ... it received the Notice of Allowance from the ... unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment ...
(Date:1/14/2014)... OTTAWA, Ontario , Jan. 14, 2014   Kinaxis ®, ... ( SCM ) and sales and operations planning ( S&OP ... the Biomanufacturing Summit , which will be held at ...  At the conference, join Kinaxis customer Elisabeth Kaszas , ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Reflects Full Scope of Integrated Global Services, ... Clinical,Trials today launches under a new name, Abt ... Associates Inc. The company will continue to,provide custom ... medical device and diagnostics industries,utilizing a team approach ...
... OF PRUSSIA, Pa., April 1, 2008 HighPoint Solutions,LLC, ... it,has been selected by a global biotechnology company to ... prepare for the company,s new,product launches and support its ... science companies continue to strive to create a holistic ...
... Increases 60% to $87.1 Million ... Increases 61% to $8.6 Million, XIAN, China, April ... Board: CBEH), (CBEH or the "Company"), an,energy company engaged ... finished oil products and the development, production and,distribution of ...
Cached Biology Technology:Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc. 2HighPoint Solutions Selected by Global Biotechnology Company to Provide Master Data Management Solution 2China Bio Energy Reports Fiscal 2007 Financial Results 2China Bio Energy Reports Fiscal 2007 Financial Results 3China Bio Energy Reports Fiscal 2007 Financial Results 4China Bio Energy Reports Fiscal 2007 Financial Results 5China Bio Energy Reports Fiscal 2007 Financial Results 6China Bio Energy Reports Fiscal 2007 Financial Results 7China Bio Energy Reports Fiscal 2007 Financial Results 8China Bio Energy Reports Fiscal 2007 Financial Results 9China Bio Energy Reports Fiscal 2007 Financial Results 10China Bio Energy Reports Fiscal 2007 Financial Results 11
(Date:4/17/2014)... in many serious conditions such as heart disease, epilepsy ... drug therapies. Unfortunately, there is still much scientists do ... fresh and unexpected insight into the structure of sodium ... molecules - which are responsible for ,fine-tuning, the activity ... most recent edition of the Journal of Biological ...
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
(Date:4/17/2014)... whereby the genetic information of DNA is used ... have numerous different functions in living organisms. Messenger ... gene expression, by relating the genetic information of ... proteins. , By examining the different types ... organism at a given time, researchers can determine ...
Breaking Biology News(10 mins):Structure of sodium channels different than previously believed 2In sex-reversed cave insects, females have the penises 2Rapid and accurate mRNA detection in plant tissues 2
... traced the origin of Plasmodium vivax , the second-worst ... published this week in Nature Communications . Until recently, ... were found only in Asian macaques, leading researchers to believe ... The study, led by researchers from the Perelman School of ...
... DNA sequencing technologies have enormous potential for the ... these new technologies, researchers are able to greatly ... key to applications including plant breeding and physiology. ... (or phylogenetic) relationships among different plant species have ...
... a spectrum of signals from hormones within a plant. ... in the roots of plants, and their journey to ... plant development. Though these phytohormones have been identified in ... within plants was previously poorly understood. Now, a ...
Cached Biology News:The parasite that escaped out of Africa 2The parasite that escaped out of Africa 3The parasite that escaped out of Africa 4Sequencing hundreds of nuclear genes in the sunflower family now possible 2Sequencing hundreds of nuclear genes in the sunflower family now possible 3Roots to shoots: Hormone transport in plants deciphered 2
This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
... OS X provides the most highly integrated ... analysis and molecular biology data management available ... Suite you can store manage view analyze ... molecular biology data all within one integrated ...
SHEEP ANTI BOVINE LACTOPEROXIDASE...
Growth Medium / Media...
Biology Products: